Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Q/C Technologies, Inc. (QCLS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Q/C Technologies, Inc. (QCLS), most recent 12 months reported: net loss $16.57M. Latest balance sheet on file: liquid cash $10.99M. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: Anbio Biotechnology · Aspira Women’s Health Inc. · BIOMERICA, INC. · VolitionRx Limited · Insight Molecular Diagnostics Inc. · Celldex Therapeutics, Inc. · Cardio Diagnostics Holdings, Inc. · Achieve Life Sciences, Inc.

Stock screener

Watchlist